DK0383417T3 - Flagmusespyt-plasminogenaktivator v-PAalfa1 - Google Patents

Flagmusespyt-plasminogenaktivator v-PAalfa1

Info

Publication number
DK0383417T3
DK0383417T3 DK90250043.8T DK90250043T DK0383417T3 DK 0383417 T3 DK0383417 T3 DK 0383417T3 DK 90250043 T DK90250043 T DK 90250043T DK 0383417 T3 DK0383417 T3 DK 0383417T3
Authority
DK
Denmark
Prior art keywords
paalfa1
flag
plasminogen activator
salivary plasminogen
salivary
Prior art date
Application number
DK90250043.8T
Other languages
English (en)
Inventor
Berthold Baldus
Peter Donner
Wolf-Dieter Schleuning
Alejandro Alagon
Werner Boidol
Joern Reiner Kraetzschmar
Bernhard Jacques Haendler
Gernot Langer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3904580A external-priority patent/DE3904580A1/de
Priority claimed from DE19893917949 external-priority patent/DE3917949A1/de
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0383417T3 publication Critical patent/DK0383417T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK90250043.8T 1989-02-13 1990-02-13 Flagmusespyt-plasminogenaktivator v-PAalfa1 DK0383417T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3904580A DE3904580A1 (de) 1989-02-13 1989-02-13 Neues thrombolytikum
DE19893917949 DE3917949A1 (de) 1989-05-30 1989-05-30 Neues thrombolytikum

Publications (1)

Publication Number Publication Date
DK0383417T3 true DK0383417T3 (da) 1996-05-13

Family

ID=25877826

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90250043.8T DK0383417T3 (da) 1989-02-13 1990-02-13 Flagmusespyt-plasminogenaktivator v-PAalfa1

Country Status (16)

Country Link
EP (1) EP0383417B1 (da)
JP (1) JP2904918B2 (da)
AT (1) ATE132187T1 (da)
AU (1) AU642404B2 (da)
BR (1) BR9007115A (da)
CA (1) CA2046632C (da)
DE (1) DE69024382T2 (da)
DK (1) DK0383417T3 (da)
ES (1) ES2085326T3 (da)
FI (1) FI103577B (da)
GR (1) GR3019328T3 (da)
HU (1) HU217219B (da)
IE (1) IE73229B1 (da)
NO (1) NO308708B1 (da)
UA (1) UA34415C2 (da)
WO (1) WO1990009438A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK176140B1 (da) * 1988-07-20 2006-09-25 Schering Ag Patentabteilung Flagermusspyt-plasminogenaktivatorer
DE3943241A1 (de) * 1989-12-22 1991-06-27 Schering Ag Thrombolytisch wirkendes kombinationspraeparat
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
US5731186A (en) * 1996-02-05 1998-03-24 Schering Aktiengesellschaft Method for the production of rDSPA α1
DE10016139A1 (de) * 2000-03-27 2001-10-18 Schleuning Wolf Dieter Verfahren zur Bestimmung von löslichem Fibrin
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
US20070072303A1 (en) * 2003-05-21 2007-03-29 Ares Trading S.A. Method of chromatographic analysis of a protein solution
DE10342518A1 (de) * 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität
GB0321997D0 (en) 2003-09-19 2003-10-22 Novartis Ag Organic compound
WO2007134617A1 (en) * 2006-05-19 2007-11-29 Paion Deutschland Gmbh Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism
KR20090078353A (ko) 2006-11-17 2009-07-17 노파르티스 아게 Ｌｉｎｇｏ 결합 분자 및 그의 제약학적 용도
DK2207808T3 (da) 2007-11-02 2013-08-05 Novartis Ag Forbedrede Nogo-A-bindingsmolekyler samt deres farmaceutiske anvendelse
EP2558580A2 (en) 2010-04-16 2013-02-20 H. Lundbeck A/S Method for the manufacture of recombinant dspa alpha1
CN114599676A (zh) 2019-10-24 2022-06-07 诺华康制药股份公司 新型抗-Nogo-A抗体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK176140B1 (da) * 1988-07-20 2006-09-25 Schering Ag Patentabteilung Flagermusspyt-plasminogenaktivatorer

Also Published As

Publication number Publication date
JPH04504799A (ja) 1992-08-27
CA2046632C (en) 1999-05-11
JP2904918B2 (ja) 1999-06-14
FI103577B1 (fi) 1999-07-30
IE73229B1 (en) 1997-05-21
DE69024382D1 (de) 1996-02-08
WO1990009438A1 (en) 1990-08-23
DE69024382T2 (de) 1996-08-14
GR3019328T3 (en) 1996-06-30
HU902004D0 (en) 1991-11-28
FI913818A0 (fi) 1991-08-12
IE900506L (en) 1990-08-13
ES2085326T3 (es) 1996-06-01
AU642404B2 (en) 1993-10-21
AU5080790A (en) 1990-09-05
CA2046632A1 (en) 1990-08-14
FI103577B (fi) 1999-07-30
HU217219B (hu) 1999-12-28
UA34415C2 (uk) 2001-03-15
NO308708B1 (no) 2000-10-16
HUT59724A (en) 1992-06-29
ATE132187T1 (de) 1996-01-15
BR9007115A (pt) 1991-11-26
EP0383417B1 (en) 1995-12-27
NO913129L (no) 1991-10-11
NO913129D0 (no) 1991-08-12
EP0383417A1 (en) 1990-08-22

Similar Documents

Publication Publication Date Title
DK0786257T3 (da) Glycolyseringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber
DE68919361D1 (de) Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
DE68929551D1 (de) Menschliche DNase
ATE96840T1 (de) Fuer die direkte expression von aktiviertem menschlichen protein-c verwendbare vektoren und zusammensetzungen.
DK0383417T3 (da) Flagmusespyt-plasminogenaktivator v-PAalfa1
FI946004A (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
NO885109D0 (no) FremgangsmŸte og middel for Ÿ forhindre blodpropp.
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
ATE120645T1 (de) Verfahren und therapeutische zubereitungen für die behandlung von gerinnungsstörungen.
DK226889A (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
DE3852625D1 (de) Vektoren und Verbindungen zur Expression von Zymogen-Formen von menschlichem Protein C.
IT8767494A0 (it) Composizione liquida per il trattamento preventivo e curativo di malattie crittogamiche di tipo oidio e procedimento per la messa in opera di tale composizione
DE3780357D1 (de) Plasminogen-aktivator und thrombolytische zusammensetzung.
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.